Ticalicibart monthly as add-on therapy to statins for nonfamilial hypercholesterolemia: the randomized, phase 3 TIMER trial
28 August 2026 (09:21 - 09:45)
Organised by: 
Abstract
About the speakers
(China)
the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an (China)
3 More presentations in this session
Associate Professor A. Navar (Dallas, US)
Doctor R. Giugliano (Boston, US)
Access the full session
The Event
ESC Congress 2026
28 August 2026
09:21 CET
You may be interested in
Congress Session
28 August 2023
Congress Presentation
Congress Presentation
Congress Presentation
